Michael Scholl Helps Make Sense of Changing Hearing Healthcare Regulations

Send us Fan Mail Starkey’s Chief Compliance Officer and EVP of Corporate Relations, Michael Scholl , joins Dave to discuss how OTC, potential Medicare expansions and other developments in Washington, D.C. will impact hearing professionals and end users, what Starkey is doing to help guide new regulations, and how hearing professionals can ensure their voices are heard. Link to full transcript

✦ Related stories ✦

Hearing Practitioner Australia·Industry news·Regulatory & legal·6w ago

Health ministers advise audiology will enter NRAS under dual profession National Board

Mandatory national registration will reshape how audiology is regulated, credentialled, and governed across Australia, with potential knock-on effects for workforce standards, scope of practice, and clinic compliance obligations.

Hearing Health Matters·Regulatory·Regulatory & legal·5d ago

U.S. Department of Labor Seeks Input on Future Standards for Occupational Hearing Loss Testing

A potential overhaul of federal occupational hearing-loss testing standards could directly reshape audiometric protocols and documentation requirements for every clinic serving industrial clients.

Hearing Review·Regulatory·Regulatory & legal·12h ago

Federal Judge Blocks Key Portion of Student Loan Rule Affecting Audiology Students

The outcome of this legal challenge could significantly affect the financial accessibility of AuD programs and, in turn, the future pipeline of audiology professionals.

Hearing Review·Blog·Regulatory & legal·7d ago

Audiology and the RISE Rule: A Blessing in Disguise?

Audiology's exclusion from the RISE Rule's professional degree designation highlights an ongoing struggle for federal recognition that could affect student loan policy, workforce pipelines, and the profession's long-term standing.

The Hearing Journal Podcast·Podcast·Regulatory & legal·3y ago

Ep. 2022-10 FDA Final Rule on OTC Hearing Aids Series, Part 1: An Overview of OTC Devices With Victor Bray, PhD, and David Akbari, AuD

Drs. Victor Bray and David Akbari provide an overview of the FDA final rule on OTC hearing aids and outline implications for the audiology profession (Part 1 of 4-part series).

Hearing Tracker·Regulatory·Regulatory & legal·2mo ago

FDA Approves Regeneron's Otarmeni, First Gene Therapy for Genetic Hearing Loss

Audiologists and ENT teams treating patients with the relevant genetic form of hearing loss should become familiar with Otarmeni's approved indication and refer eligible patients to gene therapy specialists; this is a practice-changing regulatory milestone.

The Hearing Journal Podcast·Podcast·Regulatory & legal·3y ago

Ep. 2022-10 FDA Final Rule on OTC Hearing Aids Series, Part 3: The Outlook Among the Obstacles With Stephanie Czuhajewski, MPH, CFE

Stephanie Czuhajewski discusses current and potential obstacles audiologists face following the FDA's final rule on over-the-counter hearing aids (Part 3 of 4-part series).

The Hearing Journal Podcast·Podcast·Regulatory & legal·3y ago

Ep. 2022-10 FDA Final Rule on OTC Hearing Aids Series, Part 2: The New Category of Prescription Hearing Aids With Alicia Spoor, AuD

Part 2 of a 4-part Hearing Journal Podcast series on the FDA OTC hearing aid final rule, focusing on the new prescription hearing aid category with Dr. Alicia Spoor, AuD.